
Sign up to save your podcasts
Or
In this episode, Greg and Rob discuss a recent publication regarding how 340B Program participation may impact the degree of biosimilar utilization. Additionally, the guys recap recent legislative proposals with 340B impact that were advanced by the House Energy & Commerce Committee.
Article citation: Health Affairs 42, NO. 5 (2023): 632–641
5
3232 ratings
In this episode, Greg and Rob discuss a recent publication regarding how 340B Program participation may impact the degree of biosimilar utilization. Additionally, the guys recap recent legislative proposals with 340B impact that were advanced by the House Energy & Commerce Committee.
Article citation: Health Affairs 42, NO. 5 (2023): 632–641
32,071 Listeners
105 Listeners
2,654 Listeners
43,337 Listeners
480 Listeners
16,109 Listeners
179 Listeners
389 Listeners
21 Listeners
3,352 Listeners
7 Listeners
370 Listeners
2 Listeners
7 Listeners
0 Listeners